Gene · 6238
RRBP1: ribosome binding protein 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RRBP1: ribosome binding protein 1. Genes, record 6238. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6238
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9P2E9 | Ribosome-binding protein 1 | 1,410 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents10
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 1177 | Q9P2E9 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 839 | Q9P2E9 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3783 | Q9P2E9 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 3783 | Q9P2E9 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 839 | Q9P2E9 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1177 | Q9P2E9 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 74550 | Q9P2E9 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 74553 | Q9P2E9 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 177521 | Q9P2E9 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 177524 | Q9P2E9 | Espacenet |
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,437
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RRBP1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 13 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 9 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 5 | 2025 |
| P30DK056338 | Texas Medical Center Digestive Diseases Center | 5 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 4 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 3 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 3 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 3 | 2025 |
| P30CA014599 | Cancer Center Support Grant | 3 | 2025 |
| R01AA011431 | FASD Inhibition of ASPH-Notch Mediates Adolescent Cerebral White Matter Pathology-Potential Utility of Non-invasive Extracellular Vesicle Assays | 3 | 2025 |
1 to 10 of 1,437Source NIH's project files
See all 1,437 nih grantsPapers1,971
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anandamide modulates NOTCH1 signalling and inflammatory responses during human endometrial stromal cell decidualization. | Reproduction | 2026 | 42606559 | PubTator, text mining | PubMed |
| The activity, divergence, and evolutionary degradation of modern-day homing endonucleases and their reconstructed ancestors. | bioRxiv | 2026 | 42523325 | PubTator, text mining | PubMed |
| RRBP1 promotes osimertinib resistance by activating fatty acid oxidation-dependent metabolic and immune reprogramming in EGFR-Mutant lung adenocarcinoma. | Biochem Pharmacol | 2026 | 42285369 | PubTator, text mining | PubMed |
| HES3-dependent regulatory functions in development and fusion-positive rhabdomyosarcoma. | bioRxiv | 2026 | 42146354 | PubTator, text mining | PubMed |
| New perspectives on the mechanisms and treatment of valvular heart disease: Mendelian randomization and systematic analysis based on plasma proteins. | Medicine (Baltimore) | 2026 | 41931316 | PubTator, text mining | PubMed |
| Interplay of SLC33A1-dependent and -independent Golgi sialic acid O-acetylation in CASD1 catalysis. | Nat Commun | 2026 | 41917001 | PubTator, text mining | PubMed |
| The role of Notch signalling and its crosstalk with oestrogen receptor signalling in breast cancer. | Cancer Metastasis Rev | 2026 | 41894035 | PubTator, text mining | PubMed |
| The Heterogeneity and Function of Stromal Cells in the Tumor Microenvironment. | Research (Wash D C) | 2026 | 41809407 | PubTator, text mining | PubMed |
| Detection of germline variants in human population chronically exposed to high level natural background radiation in Kerala coast. | Genes Environ | 2026 | 41761368 | PubTator, text mining | PubMed |
| Oxidative Stress-Induced DNA Damage Response Pathways in Aortic Disease: Implications for Inflammation and Vascular Degeneration. | Int J Mol Sci | 2026 | 41751991 | PubTator, text mining | PubMed |
1 to 10 of 1,971
See all 1,971 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6238
GET https://conductscience.org/api/genes/v1/6238/grants?page=2